Feed NEWBRY.ST
NE
Newbury Pharmaceuticals AB (publ)
NEWBRY.ST · STO
2.70 kr -2.53% (-0.07 kr)
1M +11.57%
Market Cap 65.1M kr
P/E Ratio -
Div. Yield -
ROE 40.34%
Valuation
93 /100
Cheap P/S 1.66x
P/B 1.45x
P/E N/A
Growth
96 /100
Growing Rev. growth 135.24%
Book val. growth 10.51%
EPS growth N/A
Profitability
15 /100
Weak Gross margin 37.81%
FCF margin 29.60%
Net margin 49.67%
Quality
6 /100
Poor ROIC 33.13%
Asset turnover 0.45x
ROE 40.34%
Debt
70 /100
Low Debt/Equity 0.00x
Net debt/EBITDA 0.81x
Current ratio 1.21x
Stability
19 /100
Unstable Beta 1.21x
Profitable years 0
Rev. volatility 97.21%
Întreabă StockBot despre NEWBRY.ST
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Karl Alexius Tiger Karlsson
Employees
7
Headquarters
Lund